Plan Nacional frente a la Resistencia a los Antibióticos PRAN
PRAN is Spain's national strategic plan against antibiotic resistance, coordinated by AEMPS under a One Health approach spanning human health, animal health, and the environment, serving the Spanish National Health System, veterinary sector, universities, and the general public.
- Company typePrivate
- Founded2014
- HeadquartersMadrid, Spain
- Headcount—
- GTM typeB2B and B2C
- OfferingServices
What Plan Nacional frente a la Resistencia a los Antibióticos PRAN does
Plan Nacional frente a la Resistencia a los Antibióticos (PRAN) is Spain's national strategic action plan to reduce the risk of selection and dissemination of antibiotic resistance, established in 2014 and coordinated by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). It operates under a One Health framework spanning human health, animal health, and the environment, with cross-ministerial support from Spain's Ministry of Health and Ministry of Agriculture. PRAN coordinates surveillance (antibiotic consumption maps, AWaRe classification tracking, ESUAvet veterinary surveillance), control (PROA programs in hospitals and community settings, REDUCE programs across livestock sectors), prevention, research, training, and public communication initiatives.
The program delivers a portfolio of digital platforms and educational products including a central website portal (resistenciaantibioticos.es), the Microcombat mobile card game app available in 19 languages, the PRANteca educational platform for university students, the PRANet collaboration workspace, and interactive surveillance dashboards. It runs annual public awareness campaigns, the Premios PRAN awards program (9 categories, €4,000 per winner), and the '¡Corre sin resistencias!' running event attracting approximately 5,000 participants in 2025. Outcomes reported include a 13.8% reduction in human health antibiotic consumption and a 60.15% reduction in animal health consumption since inception, placing Spain 1st in the EU for veterinary antibiotic reduction and 3rd for human health reduction.
PRAN is a government public health program with no commercial revenue, no equity ownership, and no investment capital. It is funded through Spanish public administration budgets, operates with approximately 8 core personnel based in Madrid, and is integrated into the European coordination framework through EU-JAMRAI 2 (120+ institutions across 30 countries) alongside formal partnerships with WHO, ECDC, EMA, EFSA, WOAH, and ISGlobal.
Plan Nacional frente a la Resistencia a los Antibióticos PRAN firmographics
Firmographics- Name
- Plan Nacional frente a la Resistencia a los Antibióticos PRAN
- Legal name
- Plan Nacional frente a la Resistencia a los Antibióticos (PRAN) — coordinated by Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
- Website
- https://resistenciaantibioticos.es
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Short description
- PRAN is Spain's national strategic plan against antibiotic resistance, coordinated by AEMPS under a One Health approach spanning human health, animal health, and the environment, serving the Spanish National Health System, veterinary sector, universities, and the general public.
- Ownership category
- akta.pro rank
Where Plan Nacional frente a la Resistencia a los Antibióticos PRAN is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Plan Nacional frente a la Resistencia a los Antibióticos PRAN business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Government Funding: PRAN is a government initiative coordinated by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), funded through public administration budgets. No commercial revenue generation.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels7 records
Plan Nacional frente a la Resistencia a los Antibióticos PRAN product offering
Product offeringCore offering
PRAN is Spain's national strategic plan coordinated by AEMPS to reduce antibiotic resistance selection and dissemination. It operates a One Health framework spanning human health, animal health, and the environment, providing surveillance systems (consumption maps, AWaRe tracking, ESUAvet), PROA optimization programs, REDUCE livestock programs, therapeutic guidelines, public awareness campaigns, and educational platforms for professionals and citizens.
Product overview
The Plan Nacional frente a la Resistencia a los Antibióticos (PRAN) is Spain's national strategic action plan coordinated by the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). It operates a central website portal as its primary digital offering, supplemented by educational applications and materials. The portfolio includes the Microcombat educational app, the PRANteca platform for university students and faculty, the PRANet internal collaboration portal for authorized partners, antibiotic consumption surveillance maps, and various awareness campaigns (including the 2025 'Usar bien los antibióticos es vital' campaign featuring Alexander Fleming). Additional resources include debate kits for schools, the antibiotic resistance symbol toolkit, and knowledge quizzes. All activities follow a One Health approach addressing human health, animal health, and environmental dimensions.
Differentiator
Problem solved
Functional benefit
Brands
- Microcombat: A card game and mobile app (available in 19 languages on Android and iOS) for educating citizens about antibiotic resistance. Players take on roles of doctors, researchers, and health workers to protect citizens from pathogens. Originally created by ISGlobal in collaboration with Laboratori de Jocs, produced with funding from the European Health Gastein Forum and ECDC, and further developed and funded by EU-JAMRAI.
- PRANteca
- PRANet
- Campaña PRAN 2025: Usar bien los antibióticos es vital
- Premios PRAN
Products and services
- PRAN Website Portal The central digital platform for Spain's National Plan Against Antibiotic Resistance, providing access to surveillance data, consumption maps, guidelines, educational materials, news, and publications across human health, animal health, and environmental sectors under a One Health approach.
- Microcombat App A mobile card game application based on an original game created by ISGlobal, designed to educate citizens about pathogen threats and antibiotic resistance through collaborative gameplay. Available in 19 languages on Android and iOS.
- PRANteca An educational platform for students and teachers in bioscience faculties at collaborating universities, providing specialized resources on antibiotic resistance and antimicrobial topics with faculty-specific access codes.
- PRANet An internal workspace portal for PRAN collaborators, providing secure access to working documents and coordination tools for participating organizations.
- Kit de Debate para Colegios e Institutos A didactic card game kit for students aged 11-18 featuring 8 characters representing different perspectives on antibiotic resistance, designed to teach debate skills and understanding of the prescription deferral system.
- Antibiotic Consumption Maps Interactive maps displaying antibiotic consumption data across human health (primary care, hospitals) and veterinary sectors, including AWaRe category breakdowns and regional comparisons by autonomous communities.
- Antibiotic Format Adjustment Initiative A program coordinated by AEMPS to adjust antibiotic packaging sizes to align with standard treatment guidelines, reducing household surpluses and self-medication risks.
- PROA Programs (Antibiotic Optimization Programs) Antibiotic Optimization Programs (Programas de Optimización de Uso de los Antibióticos) for hospital and community settings with certification systems for PROA teams, providing guidelines and quality assurance.
- REDUCE Programs (Animal Health) Programs for reducing antibiotic use in livestock across multiple categories including porcine, poultry, aquaculture, ovino/caprino, bovine, rabbits, and small animals.
Quantifiable outcome
- 13.8% reduction in human health antibiotic consumption since PRAN inception
- +4 more outcomes
Companies that use Plan Nacional frente a la Resistencia a los Antibióticos PRAN
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles5 records
Plan Nacional frente a la Resistencia a los Antibióticos PRAN technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Plan Nacional frente a la Resistencia a los Antibióticos PRAN partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- EU-JAMRAI 2 (European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections)coreEuropean joint action involving more than 120 institutions from 30 countries working to reinforce coordination in Europe against antimicrobial resistance and healthcare-associated infections. AEMPS leads the communication and awareness area.
- ISGlobal (Barcelona Institute for Global Health)coreCollaboration on educational materials including Microcombat game app and original card game concept. ISGlobal collaborated with Laboratori de Jocs to create the original game idea.
- Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)coreAEMPS is the coordinating body of PRAN, providing institutional support, regulatory authority, and operational resources for all PRAN activities.
- Spanish Universities NetworkcoreCollaboration with universities including Universidad Complutense de Madrid, Universidad de Córdoba, Universidad de Murcia, Universidad del País Vasco, Universidad de Salamanca, Universidad de Sevilla, and Universidad de Valencia for educational programs, PRANteca platform, and awareness events.
- SEFAC (Sociedad Española de Farmacia Familiar y Comunitaria)minorCollaboration on research study to understand perception of pharmacists and patients regarding causes of antibiotic resistance.
- SEFH (Sociedad Española de Farmacia Hospitalaria)minorCollaboration on Platform for Monitoring Antibiotic Consumption in Hospital Settings in Spain.
- CSIC (Consejo Superior de Investigaciones Científicas)minorCSIC invited PRAN team to learn about antibiotic resistance research through their Cicerón program, visiting CNB-CSIC and meeting with researchers working on resistance from different perspectives.
- EFSA (European Food Safety Authority)coreEuropean authority collaborating on integrated surveillance systems and One Health approach to antimicrobial resistance.
- ECDC (European Centre for Disease Prevention and Control)coreEuropean center for disease prevention collaborating on surveillance, awareness campaigns, and European Antibiotic Awareness Day activities.
- EMA (European Medicines Agency)coreEuropean Medicines Agency collaborating on veterinary and human medicine aspects of antimicrobial resistance, joint strategies, and integrated surveillance.
- WHO (World Health Organization)coreWHO collaborating on AWaRe classification system, global awareness campaigns including World Antimicrobial Awareness Week, and international coordination.
- WOAH (World Organisation for Animal Health)coreInternational animal health organization collaborating on One Health approach and veterinary aspects of antimicrobial resistance.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
Plan Nacional frente a la Resistencia a los Antibióticos PRAN competitors and assessment
Company assessmentDirect peers
- UK Health Security Agency (UKHSA) AMR Programme: UK's national AMR coordination programme with comparable mandate in surveillance, antimicrobial stewardship, and public awareness campaigns. Operates as a government-led One Health programme addressing human and animal antibiotic resistance, making it the closest direct peer to PRAN.
- Santé Publique France: France's national public health agency with parallel functions in antimicrobial resistance surveillance, prevention, and public awareness campaigns. Operates a comparable national AMR strategy with similar One Health scope.
- Robert Koch Institute (RKI): Germany's federal public health institute coordinating the national AMR strategy (DART) with comparable surveillance, stewardship, and One Health functions. Provides a directly comparable model of government-led AMR coordination.
- ReAct: International independent AMR action network working globally on antibiotic resistance with parallel advocacy, awareness, and policy influence goals. Functions as a non-governmental counterpart with comparable mission focus on AMR reduction.
Broad incumbents
- European Centre for Disease Prevention and Control (ECDC): EU-level agency coordinating AMR surveillance across member states, European Antibiotic Awareness Day, and joint stewardship initiatives. Operates a broader EU-wide scope than PRAN but shares the same fundamental mission and partners with PRAN through EU-JAMRAI.
- Centers for Disease Control and Prevention (CDC) AMR Programs: US federal agency with broader public health scope but significant AMR programmes including AR Lab Network, stewardship initiatives, and public awareness. Provides a comparable but much larger-scale model of government-led AMR coordination.
- World Health Organization (WHO) AMR: Global coordinator for AMR strategy through the AWaRe classification, Tripartite Joint Secretariat with WOAH and FAO, and World Antimicrobial Awareness Week. Operates a broader global mandate and sets the frameworks PRAN implements nationally.
- WOAH (World Organisation for Animal Health): Global intergovernmental animal health organization coordinating AMR response in veterinary sectors under the One Health approach. Addresses the animal health component that PRAN manages nationally, with a much broader global scope.
Others
- ISGlobal (Barcelona Institute for Global Health): Key PRAN partner that co-developed the Microcombat educational app and contributes research expertise on AMR. Functions as an enabling research and policy partner rather than a direct competitor, but works on closely related AMR themes.
- EU-JAMRAI: European Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections involving 120+ institutions from 30 countries. A core partner of PRAN with broader EU-wide coordination mandate, providing the platform through which PRAN's methodology scales.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Plan Nacional frente a la Resistencia a los Antibióticos PRAN financial estimates
Financial estimateRevenue estimate
Valuation estimate
Plan Nacional frente a la Resistencia a los Antibióticos PRAN leadership team
Management profileNumber of profiles
Profiles3 records
Plan Nacional frente a la Resistencia a los Antibióticos PRAN funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Plan Nacional frente a la Resistencia a los Antibióticos PRAN M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Plan Nacional frente a la Resistencia a los Antibióticos PRAN
What does Plan Nacional frente a la Resistencia a los Antibióticos PRAN do?
PRAN is Spain's national strategic plan coordinated by AEMPS to reduce antibiotic resistance selection and dissemination. It operates a One Health framework spanning human health, animal health, and the environment, providing surveillance systems (consumption maps, AWaRe tracking, ESUAvet), PROA optimization programs, REDUCE livestock programs, therapeutic guidelines, public awareness campaigns, and educational platforms for professionals and citizens.
Is Plan Nacional frente a la Resistencia a los Antibióticos PRAN a public or private company?
Plan Nacional frente a la Resistencia a los Antibióticos PRAN is a private company. It is classified as state government owned and is currently operating.
When was Plan Nacional frente a la Resistencia a los Antibióticos PRAN founded?
Plan Nacional frente a la Resistencia a los Antibióticos PRAN was founded in 2014.
Where is Plan Nacional frente a la Resistencia a los Antibióticos PRAN based?
Plan Nacional frente a la Resistencia a los Antibióticos PRAN is headquartered in Madrid, Spain, in the Europe region.
How does Plan Nacional frente a la Resistencia a los Antibióticos PRAN make money?
One revenue line is on record: government Funding.
Who are Plan Nacional frente a la Resistencia a los Antibióticos PRAN's main competitors?
Direct peers on record are UK Health Security Agency (UKHSA) AMR Programme, Santé Publique France, Robert Koch Institute (RKI) and ReAct. Broad incumbents are European Centre for Disease Prevention and Control (ECDC), Centers for Disease Control and Prevention (CDC) AMR Programs, World Health Organization (WHO) AMR and WOAH (World Organisation for Animal Health). Others are ISGlobal (Barcelona Institute for Global Health) and EU-JAMRAI.
Does Plan Nacional frente a la Resistencia a los Antibióticos PRAN have an API?
No public API is recorded for Plan Nacional frente a la Resistencia a los Antibióticos PRAN.